EuroPCR 2014: St. Jude touts EnligHTN data amid renal denervation backlash

St. Jude Medical says that its next-gen EnligHTN renal denervation system appears safe and effective in treating hypertension, but docs at this year's EuroPCR conference are calling for more robust clinical trials.

EuroPCR, Medtronic, St. Jude Medical

News Well, Clinical Trials, Hypertension, Conference coverage, Minnesota, Renal

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1jZtbtc